At standard once-daily dosing, this is a six-month supply, making the effective monthly cost under $3 difficult to beat in this category
Notice that at 5mg/mL, even the starting dose of 2.5mg requires 50 units
Contact your pharmacy or PlexusDx provider immediately
Key results: 15 mg dose: Average weight loss of 22.5 percent (approximately 52 pounds for a 230-pound individual) 10 mg dose: Average weight loss of 21.4 percent 5 mg dose: Average weight loss of 16.0 percent Over 85 percent of participants at 10 mg or 15 mg lost at least 10 percent of body weight Over 50 percent at 15 mg lost at least 20 percent SURMOUNT-5, a head-to-head trial comparing tirzepatide to semaglutide, confirmed tirzepatides superiority at matched doses
An ultrasonicator (Sonix, IL, USA) was used to sonicate QTLN formulations for 30 min
What Clinical Trials Tell Us About Long-Term Safety The long-term safety of semaglutide is among the most thoroughly studied of any weight loss medication